Darunavir Inhibitory Quotient Predicts the 48-Week Virological Response to Darunavir-Based Salvage Therapy in Human Immunodeficiency Virus-Infected Protease Inhibitor-Experienced Patients

The aim of this study was to evaluate the relationship between the virological response to darunavir-based salvage antiretroviral therapy and the darunavir genotypic and virtual inhibitory quotients (gIQ and vIQ, respectively). Thirty-seven HIV-infected patients failing protease inhibitor-based anti...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Moltó, José, Santos, José R., Pérez-Álvarez, Nuria, Cedeño, Samandhy, Miranda, Cristina, Khoo, Saye, Else, Laura, Llibre, Josep Maria, Valle, Marta, Clotet, Bonaventura
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology (ASM) 2008
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2573097/
https://ncbi.nlm.nih.gov/pubmed/18725446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00520-08
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak